Kazuhito Suzuki
Minato, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Aplastic anemia developed after treatment with durvalumab
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: August 23, 2026
Treatment strategies for newly diagnosed multiple myeloma and the clinical significance of minimal residual disease negativity
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 03, 2026
Plasmablastic lymphoma through clonal expansion 17 years after EBV-positive DLBCL: case report and review.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: May 31, 2026
Schlafen 11 (SLFN11) overexpression and nucleolar localization in response to bortezomib in multiple myeloma.
Journal: bioRxiv : the preprint server for biology
Published: April 29, 2026
Surgical Treatment for an Infectious Aneurysm Caused by Perclose ProGlide®: A Case Study.
Journal: Cureus
Published: April 14, 2026
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.
Journal: International journal of clinical oncology
Published: April 11, 2026
Schlafen 11 (SLFN11) is overexpressed in multiple myeloma and undergoes nucleolar translocation in response to bortezomib.
Journal: Cancer research communications
Published: February 25, 2026
Recent advances in the pathophysiology and treatment of plasma cell dyscrasias.
Journal: International journal of hematology
Published: December 17, 2025
Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.
Journal: Japanese journal of clinical oncology
Published: December 16, 2025
Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan.
Journal: Current medical research and opinion
Published: November 26, 2025
Wild-Type Transthyretin Amyloid Cardiomyopathy With Bone Marrow Involvement: Clinical Implications of Less Common Sites of Amyloid Deposition.
Journal: Cureus
Published: September 21, 2025
Last Updated: 09/26/2026